Repeat doses of antenatal steroids and hypothalamic-pituitary-adrenal axis (HPA) function

American Journal of Obstetrics and Gynecology

Volumn 197, Issue 1, 2007, Pages 40.e1-40.e6

  Battin, Malcolm R ^a,b   Bevan, Coila ^a   Harding, Jane E ^a,b  

^a UNIVERSITY OF AUCKLAND   (New Zealand)

^b UNIVERSITY OF AUCKLAND   (New Zealand)

Author keywords

neonatal adrenal suppression; randomized trial; repeat corticosteroids

Indexed keywords

BETAMETHASONE; CORTICOTROPIN; HYDROCORTISONE; METYRAPONE; PLACEBO;

ADULT; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORTICOTROPIN BLOOD LEVEL; DRUG EFFECT; FEMALE; HUMAN; HUMAN EXPERIMENT; HYDROCORTISONE BLOOD LEVEL; HYPOTHALAMUS HYPOPHYSIS ADRENAL SYSTEM; INFANT; INFORMED CONSENT; MALE; OBSERVATIONAL METHOD; PREMATURE LABOR; PRENATAL DRUG EXPOSURE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; REPEATED DRUG DOSE; STATISTICAL ANALYSIS; TREATMENT DURATION; TREATMENT RESPONSE;

EID: 34347217825     PISSN: 00029378     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ajog.2007.02.015     Document Type: Article

References (47)

1. Liggins G.C., and Howie R.N. A controlled trial of antepartum glucocorticoid treatment for prevention of the respiratory distress syndrome in premature infants. Pediatrics 50 (1972) 515-525
2. Crowley P. Prophylactic corticosteroids for preterm birth. Cochrane Database Syst Rev 2 (2000) CD000170
3. Effect of corticosteroids for fetal maturation on perinatal outcomes. NIH Consensus Development Panel on the Effect of Corticosteroids for Fetal Maturation on Perinatal Outcomes. Anonymous. JAMA 273 (1995) 413-418
4. Crowther C.A., and Harding J. Repeat doses of prenatal corticosteroids for women at risk of preterm birth for preventing neonatal respiratory disease. Cochrane Database Syst Rev 3 (2003) CD003935
5. Brocklehurst P., Gates S., McKenzie-McHarg K., Alfirevic Z., and Chamberlain G. Are we prescribing multiple courses of antenatal corticosteroids?. A survey of practice in the UK. BJOG 106 (1999) 977-979
6. Quinlivan J.A., Evans S.F., Dunlop S.A., Beazley L.D., and Newnham J.P. Use of corticosteroids by Australian obstetricians-a survey of clinical practice. Aust N Z J Obstet Gynaecol 38 (1998) 1-7
7. Hingre R.V., Gross S.J., Hingre K.S., Mayes D.M., and Richman R.A. Adrenal steroidogenesis in very low birth weight preterm infants. J Clin Endocrinol Metabol 78 (1994) 266-270
8. Helbock H.J., Insoft R.M., and Conte F.A. Glucocorticoid-responsive hypotension in extremely low birth weight newborns. Pediatrics 92 (1993) 715-717
9. Lee M.M., Rajagopalan L., Berg G.J., and Moshang Jr. T. Serum adrenal steroid concentrations in premature infants. J Clin Endocrinol Metabol 69 (1989) 1133-1136
10. Korte C., Styne D., Merritt T.A., Mayes D., Wertz A., and Helbock H.J. Adrenocortical function in the very low birth weight infant: improved testing sensitivity and association with neonatal outcome. J Pediatr 128 (1996) 257-263
11. Watterberg K.L., Scott S.M., Backstrom C., Gifford K.L., and Cook K.L. Links between early adrenal function and respiratory outcome in preterm infants: airway inflammation and patent ductus arteriosus. Pediatrics 105 (2000) 320-324
12. Watterberg K.L., Gerdes J.S., and Cook K.L. Impaired glucocorticoid synthesis in premature infants developing chronic lung disease. Pediatr Res 50 (2001) 190-195
13. Strauss A., Brakin M., Norris K., and Modanlou H.D. Adrenal responsiveness in very-low-birth-weight infants treated with dexamethasone. Dev Pharmacol Ther 19 (1992) 147-154
14. Benediktsson R., Lindsay R.S., Noble J., Seckl J.R., and Edwards C.R. Glucocorticoid exposure in utero: new model for adult hypertension. Lancet 341 (1993) 339-341
15. Dodic M., Moritz K., and Wintour E.M. Prenatal exposure to glucocorticoids and adult disease. Arch Physiol Biochem 111 (2003) 61-69
16. Newnham J.P. Is prenatal glucocorticoid administration another origin of adult disease?. Clin Exp Pharmacol Physiol 28 (2001) 957-961
17. Phillips D.I., Barker D.J., Fall C.H., et al. Elevated plasma cortisol concentrations: a link between low birth weight and the insulin resistance syndrome?. J Clin Endocrinol Metabol 83 (1998) 757-760
18. Seckl J.R. Prenatal glucocorticoids and long-term programming. Eur J Endocrinol 151 (2004) U49-U62
19. Ng P.C., Wong G.W., Lam C.W., et al. Pituitary-adrenal suppression and recovery in preterm very low birth weight infants after dexamethasone treatment for bronchopulmonary dysplasia. J Clin Endocrinol Metabol 82 (1997) 2429-2432
20. Ng P.C., Blackburn M.E., Brownlee K.G., Buckler J.M., and Dear P.R. Adrenal response in very low birthweight babies after dexamethasone treatment for bronchopulmonary dysplasia. Arch Dis Child 64 (1989) 1721-1726
21. Ford L.R., Willi S.M., Hollis B.W., and Wright N.M. Suppression and recovery of the neonatal hypothalamic-pituitary-adrenal axis after prolonged dexamethasone therapy. J Pediatr 131 (1997) 722-726
22. Scott S.M., Backstrom C., and Bessman S. Effect of five days of dexamethasone therapy on ventilator dependence and adrenocorticotropic hormone-stimulated cortisol concentrations. J Perinatol 17 (1997) 24-28
23. Wilson D.M., Baldwin R.B., and Ariagno R.L. A randomized, placebo-controlled trial of effects of dexamethasone on hypothalamic-pituitary-adrenal axis in preterm infants. J Pediatr 113 (1988) 764-768
24. Ng P.C., Wong G.W., Lam C.W., et al. Pituitary-adrenal response in preterm very low birth weight infants after treatment with antenatal corticosteroids. J Clin Endocrinol Metabol 82 (1997) 3548-3552
25. Noguchi A., and Reynolds J.W. Serum cortisol and dehydroepiandrosterone sulfate responses to adrenocorticotropin stimulation in premature infants. Pediatr Res 12 (1978) 1057-1061
26. Dorr H.G., Versmold H.T., Sippell W.G., Bidlingmaier F., and Knorr D. Antenatal betamethasone therapy: effects on maternal, fetal, and neonatal mineralocorticoids, glucocorticoids, and progestins. J Pediatr 108 (1986) 990-993
27. Banks B.A., Cnaan A., Morgan M.A., et al. Multiple courses of antenatal corticosteroids and outcome of premature neonates. North American Thyrotropin-Releasing Hormone Study Group. Am J Obstet Gynecol 181 (1999) 709-717
28. Bradley B.S., Kumar S.P., Mehta P.N., and Ezhuthachan S.G. Neonatal cushingoid syndrome resulting from serial courses of antenatal betamethasone. Obstet Gynecol 83 (1994) 869-872
29. Ng P.C., Wong G.W., Lam C.W., et al. Effect of multiple courses of antenatal corticosteroids on pituitary-adrenal function in preterm infants. Arch Dis Child Fetal Neonatal Ed 80 (1999) F213-F216
30. Ashwood PJ C.C., Willson K.J., Haslam R.R., Kennaway D.J., Hiller J.E., and Robinson J.S. Neonatal adrenal function after repeat dose prenatal corticosteroids: a randomized controlled trial. Am J Obstet Gynecol 194 (2006) 861-867
31. Crowther C.A., Haslam R.R., Hiller J.E., Doyle L.W., Robinson J.S., and Australasian Collaborative Trial of Repeat Doses of Steroids (ACTORDS) Study Group. Repeat doses of prenatal corticosteroids for women at risk of preterm birth-The ACTORDS Trial. Lancet 367 (2006) 1913-1919
32. Lewis J.G., Yeo K.H., and Elder P.A. A competitive enzyme-linked immunosorbent assay for plasma 11-deoxycortisol (17,21-dihydroxy-4-pregnene-3,20-dione). Steroids 47 (1986) 365-372
33. Rizvi Z.B., Aniol H.S., Myers T.F., Zeller W.P., Fisher S.G., and Anderson C.L. Effects of dexamethasone on the hypothalamic-pituitary-adrenal axis in preterm infants. J Pediatr 120 (1992) 961-965
34. Eskola V., Lenko H.L., and Tammela O. Impaired adrenocortical function in very low birth weight infants after multiple pregnancies. Eur J Endocrinol 149 (2003) 529-534
35. Metzger D.L., Wright N.M., Veldhuis J.D., Rogol A.D., and Kerrigan J.R. Characterization of pulsatile secretion and clearance of plasma cortisol in premature and term neonates using deconvolution analysis. J Clin Endocrinol Metabol 77 (1993) 458-463
36. Arnold J.D., Bonacruz G., Leslie G.I., Veldhuis J.D., Milmlow D., and Silink M. Antenatal glucocorticoids modulate the amplitude of pulsatile cortisol secretion in premature neonates. Pediatr Res 44 (1998) 876-881
37. Alkalay A.L., Pomerance J.J., Puri A.R., et al. Hypothalamic-pituitary-adrenal axis function in very low birth weight infants treated with dexamethasone. Pediatrics 86 (1990) 204-210
38. Alkalay A.L., Klein A.H., Nagel R.A., and Pomerance J.J. Evaluation of hypothalamic-pituitary-adrenal axis in premature infants treated with dexamethasone. Am J Perinatol 13 (1996) 473-477
39. Guinn D.A., Atkinson M.W., Sullivan L., et al. Single vs weekly courses of antenatal corticosteroids for women at risk of preterm delivery: a randomized controlled trial. [see comment]. JAMA 286 (2001) 1581-1587
40. French N.P., Hagan R., Evans S.F., Godfrey M., and Newnham J.P. Repeated antenatal corticosteroids: size at birth and subsequent development. Am J Obstet Gynecol 180 (1999) 114-121
41. French N.P., Hagan R., Evans S.F., Mullan A., and Newnham J.P. Repeated antenatal corticosteroids: effects on cerebral palsy and childhood behavior. Am J Obstet Gynecol 190 (2004) 588-595
42. Levitt N.S., Lindsay R.S., Holmes M.C., and Seckl J.R. Dexamethasone in the last week of pregnancy attenuates hippocampal glucocorticoid receptor gene expression and elevates blood pressure in the adult offspring in the rat. Neuroendocrinol 64 (1996) 412-418
43. Uno H., Eisele S., Sakai A., et al. Neurotoxicity of glucocorticoids in the primate brain. Horm Behav 28 (1994) 336-348
44. Sloboda D.M., Moss T.J., Gurrin L.C., Newnham J.P., and Challis J.R. The effect of prenatal betamethasone administration on postnatal ovine hypothalamic-pituitary-adrenal function. J Endocrinol 172 (2002) 71-81
45. Sloboda D.M., Moss T.J., Li S., Doherty D.A., Nitsos I., Challis J.R., and Newnham J.P. Hepatic glucose regulation and metabolism in adult sheep: effects of prenatal betamethasone. Am J Physiol Endocrinol Metab 289 (2005) E721-E728
46. Miller N.M., Fisk N.M., Modi N., and Glover V. Stress responses at birth: determinants of cord arterial cortisol and links with cortisol response in infancy. BJOG 112 (2005) 921-926
47. Dalziel S.R., Walker N.K., Parag V., et al. Cardiovascular risk factors after antenatal exposure to betamethasone: 30-year follow-up of a randomised controlled trial. Lancet 365 (2005) 1856-1862